Research ArticleCancer

Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade

See allHide authors and affiliations

Science Translational Medicine  25 Nov 2015:
Vol. 7, Issue 315, pp. 315ra188
DOI: 10.1126/scitranslmed.aac4925

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article